Skip to content
Clinical Trials – home
Helse Bergen HF
Sponsor

Helse Bergen HF

Norway Haukelandsveien 22, 5021 Bergen, Norway

About the sponsor

Clinical research includes acute myeloid leukemia, high-risk myelodysplastic syndrome, breast cancer, pancreatic cancer, and recurrent grade IV glioma. The funded studies also address treatment response, resistance, and survival in aggressive cancer settings.

  • Acute myeloid leukemia
  • Breast cancer
  • Pancreatic cancer
  • Recurrent grade IV glioma

Research activity spans both solid tumours and blood cancers, with interest in personalised treatment strategies and disease control in difficult-to-treat malignancies.

About Specializations

Helse Bergen HF runs clinical trials in conditions such as Multiple sclerosis, Chronic fatigue syndrome, Cluster headache, Breast cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

26 clinical trials

Countries:NorwayNorway
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Tenofovir Alafenamide
  • Sponsor:Helse Bergen HF
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Macrogol 3350
  • Sponsor:Helse Bergen HF
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Daratumumab
  • Sponsor:Helse Bergen HF
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Helse Bergen HF
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Metyrapone
  • Sponsor:Helse Bergen HF
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Dexamfetamine Sulfate
  • Sponsor:Helse Bergen HF
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Sodium Chloride
  • Sponsor:Helse Bergen HF
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Methylprednisolone
  • Sponsor:Helse Bergen HF
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Hydroxycarbamide
  • Sponsor:Helse Bergen HF
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:Helse Bergen HF
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Nitrous Oxide
  • Sponsor:Helse Bergen HF
Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Helse Bergen HF

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.